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Toxoplasma gondii, the causative agent of toxoplasmosis, is a widespread intracellular
parasite able to infect virtually any nucleated cell. T. gondii infection of activated
macrophages inhibits nitric oxide (NO) production; however, parasite effectors
responsible for this block have not been defined. Macrophage populations are extremely
heterogeneous, responding differently to stimuli and to parasite infection. Here we
evaluated the inhibition of NO production caused by T. gondii infection of J774-A1 and
RAW 264.7 macrophages and assessed the role of several known parasite virulence
factors in this phenotype. Infection of activated macrophages from both macrophage
lines reduced NO production, however, the mechanism of this decrease was different.
Consistent with previous reports, infected J774-A1 macrophages had reduced iNOS
expression and lower number of iNOS positive cells. In contrast, T. gondii infection of
RAW 264.7 macrophages did not alter iNOS expression or the number of iNOS positive
cells, and yet it led to lower levels of NO production. Deletion of a number of previously
defined virulence factors including ROP kinases that disrupt innate immune factors,
TgIST which blocks STAT1 activation, as well as the secretory trafficking proteins ASP5
and MYR1, did not alter the phenotype of decreased NO production. Taken together our
findings indicate that T. gondii infection inhibits NO production of activated macrophages
by different mechanisms that involve reduction of iNOS expression vs. iNOS impairment,
and suggest that a novel parasite effector is involved in modulating this important host
defense pathway.
Keywords: Toxoplasma gondii, virulence factors, macrophages, inducible nitric oxide synthase, nitric oxide

Abbreviations: ASP5, aspartyl protease 5; GRA, dense granule proteins; iNOS, inducible nitric oxide synthase; IRGs,
immunity related GTPases; MYR1, myc regulation 1; NO, nitric oxide; ROP, rhoptry proteins; TgIST, Toxoplasma gondii
inhibitor of STAT1-dependent transcription.
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the proteasome (Padrao Jda et al., 2014). Although TGF-β 1
is involved in the inhibition of NO production in infected
activated macrophages (Seabra et al., 2004), the parasite effector
responsible for iNOS degradation and NO inhibition still remains
elusive. In addition, most of these studies have been done
in vitro with a single cell type and without comparison of other
macrophage cell lines.
Macrophages are an extremely heterogeneous cell population
with many subpopulations that behave differently (Geissmann
et al., 2010). Thus, T. gondii has to deal with many distinct
macrophage subpopulations during host infection. To
better understand how T. gondii copes with NO production
of distinct activated macrophages lines, production of
this microbicidal molecule and expression of iNOS were
compared in two macrophage cell lines after infection.
In addition, several previously described virulence factors
were also analyzed as possible effectors responsible for NO
inhibition of infected activated macrophages. This study
reveals intrinsic differences between both macrophage cell
lines in activation patterns and mechanisms by which
T. gondii infection disrupted NO production. Furthermore,
previously identified virulence effectors that were tested here
did not alter the NO inhibition phenotype detected in both
macrophages cell lines, indicating that a novel effector is
responsible for the inhibition of this important host microbicidal
molecule.

INTRODUCTION
Toxoplasmosis is a worldwide disease affecting about one-third of
the human population (Tenter et al., 2000). Toxoplasma gondii,
the causative agent of toxoplasmosis, is an obligate intracellular
parasite that infects distinct host cells (Tenter et al., 2000).
Macrophages are key players of the host immune system and
are able to control T. gondii replication following activation
by interferon gamma and a second signal provide by LPS
or TNF-α (Adams et al., 1990; Sibley et al., 1991). One of
the main components of antimicrobial activities of activated
macrophages is the production of NO through the induction of
iNOS (MacMicking et al., 1997). Generation of NO has been
implicated in control of chronic toxoplasmosis (Chao et al., 1993;
Khan et al., 1997; Scharton-Kersten et al., 1997; Roberts et al.,
2000). However, T. gondii coevolved with its host and evasion
mechanisms have emerged to thwart many of the effectors of
activated macrophages. Included among these virulence factors
are proteins released from rhoptries that block innate immunity
(Hunter and Sibley, 2012) and dense granules that alter host cell
transcription (Hakimi et al., 2017).
During host cell invasion, T. gondii secretes contents from
specialized secretory organelles including rhoptries and dense
granules that have a central role in parasitophorous vacuole
formation and host immunity subversion (Carruthers and Sibley,
1997; Bougdour et al., 2013; Braun et al., 2013; Etheridge et al.,
2014; Olias et al., 2016). For example, the ROP5-ROP17-ROP18
complex, which is secreted from rhoptries, blocks the assembly
and function of vacuolar-targeted IRGs (Saeij et al., 2006; Taylor
et al., 2006; Behnke et al., 2011; Reese et al., 2011; Etheridge
et al., 2014). Recruitment of IRGs to the vacuole normally results
in its destruction and death of the parasite (Zhao et al., 2009;
Khaminets et al., 2010), but ROPs of virulent strains of the
parasite are able to phosphorylate key IRG proteins, inhibiting
their activity and assembly, protecting T. gondii (Fentress et al.,
2010; Steinfeldt et al., 2010). Proteins from GRA are another
important class of virulence factors secreted by T. gondii during
and after host cell invasion that perform major roles in parasite
survival and replication (Mercier et al., 2002). For example,
GRA16 down-modulates host p53 expression changing the cell
cycle (Bougdour et al., 2013), while GRA24 causes host p38α
activation, leading to a strong proinflammatory response (Braun
et al., 2013). Recently, another important T. gondii virulence
factor known as inhibitor of STAT1-dependent transcription
(IST) has been described (Gay et al., 2016; Olias et al., 2016).
IST translocates to the host nucleus where it recruits a repressive
complex of STAT1 promoters, blocking the IFN-γ dependent
transcription, avoiding host cell activation (Olias et al., 2016).
Classically activated macrophages produce NO that control
T. gondii replication (Adams et al., 1990; Bohne et al., 1994; Khan
et al., 1997). NO is an important microbicidal molecule that is
produced by iNOS (Stuehr et al., 1991; Xie et al., 1994; Lowenstein
and Padalko, 2004). It is well known that T. gondii evades the
cytotoxic effects of NO by inhibiting NO production of activated
mice peritoneal macrophages (Dobbin et al., 2002; Seabra et al.,
2002, 2004; Luder et al., 2003). Furthermore, in activated
J774-A1 macrophages, infection causes iNOS degradation by
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MATERIALS AND METHODS
Biosecurity and Institutional Safety
Procedures
This study was carried out in accordance with the NIH standard
biosecurity and institutional safety procedures of Washington
University School of Medicine.

Toxoplasma gondii and Cell Culture
Knockout parasites used in this work were previously generated
as reported: RH1ku80 (Fox et al., 2009); 1rop5 (Behnke et al.,
2011); 1rop17, 1rop17/18, 1rop18 (Etheridge et al., 2014);
1TgIST (Olias et al., 2016); (1asp5) (Curt-Varesano et al., 2016);
(1myr1) (Franco et al., 2016). Wild type T. gondii tachyzoites,
deficient in Ku80 (RH1ku80) and knockout parasites, all of the
RH strain, were maintained by serial passage in Human Foreskin
Fibroblast (HFF) monolayers. Parasites were released from HFF
using a cell scraper (TPP, Switzerland). The cell suspension was
passed three times in a 10 ml syringe (BD, United States) with a
22-gauge needle (CML Supply, United States) and it was filtered
on a 3 µm Whatman Nuclepore membrane (GE Healthcare Life
Sciences, United States).
Human Foreskin Fibroblast cells were obtained from
the Boothroyd laboratory at Stanford University. HFF
cells and the mouse macrophage cell lines RAW 264.7
(ATCC TIB-71, United States, from BALB/c mice ascites
after Abelson murine leukemia virus inoculation) and
J774-A1 (ATCC TIB-67, United States, from BALB/c
mice ascites after reticulum cell sarcoma inoculation)
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temperature and nitrite was read in a plate reader (BioTek,
United States) at 540 nm. The nitrite value was calculated from
a calibrated standard curve using sodium nitrite ranging from 0
to 100 µM.

were cultivated in Dulbecco’s modified Eagle’s medium
(DMEM - Invitrogen, United States) supplemented with
10% HyClone Fetal Bovine Serum (FBS - GE Healthcare
Life Sciences, United States), 10 mM glutamine (Thermo
Fisher Scientific, United States) and 10 µg/ml gentamicin
(Gibco, United States) in an incubator (Thermo Fisher
Scientific, United States) at 37◦ C in 5% CO2 atmosphere.
Cultures were negative for Mycoplasma spp. contamination
with the e-Myco plus PCR detection kit (Boca Scientific,
United States).

In-Cell-ELISA
Infection of parental and knockout parasites into RAW 264.7 and
J774-A1 macrophages was evaluated after 2 h of challenge in cells
seeded in 96-well plates, activated and infected as described. After
infection, cells were fixed and permeabilized for 30 min in PBS
containing 4% formaldehyde (Polysciences, Inc., United States),
0.05% Triton X-100 (Fisher BioReagents, United States), washed
with PBS and blocked for 30 min with 5% FBS and Normal Goat
Serum (Sigma-Aldrich, United States) in PBS (FBS-NGS). Cells
were incubated for 1 h with anti-RH (SAG1) rabbit antibody
diluted 1:2000 in FBS-NGS, washed twice and incubated for
1 h with anti-rabbit HRP conjugated antibody (Life Technology,
United States) diluted 1:4000 in FBS-NGS. Cells were washed
three times, incubated for 15 min with 100 µl of TMB substrate
(BD OptEIA, Thermo Fisher Scientific, United States), reaction
stopped with 100 µl of 1M H2 SO4 and the absorbance was read
in a plate reader (BioTek, United States) at 450 nm. Non-infected
macrophages were used as negative control.

Generation of 1rop16 Knockout
Parasites
The knockout plasmid construct for ROP16 was created using the
three-fragment GatewayTM recombination system (Invitrogen,
United States), joining two constructs homologous to the 50 and
30 flanks of ROP16 with a central HXGPRT expression cassette,
as described previously (Etheridge et al., 2014). This plasmid
was transfected into RH1hxgprt1ku80 parasites, and resistant
pools were expanded under treatment with mycophenolic acid
(15 µg/ml) acid and xanthine (50 µg/ml). After PCR (Applied
Biosystems, United States) confirmation of construct integration
in the pool, parasites were subcloned by limiting dilution in 96well plates (TPP, Switzerland) containing confluent monolayers
of HFF cells. Clones were identified by visual confirmation of
single plaques, screened by PCR to confirm replacement of the
coding region of ROP16 with the HXGPRT cassette, expanded by
growth on HFF monolayers, and cryo-preserved.

Immunofluorescence Assay
RAW 264.7 and J774-A1 macrophages were seeded at the
density of 5 × 105 cells per well over coverslips (Fisherbrand,
United States) in 24-well plates (TPP, Switzerland), activated
and infected as described. Cells were fixed for 30 min with PBS
containing 4% formaldehyde, permeabilized for 15 min in PBS
containing 0.1% Triton X-100, incubated for 30 min with PBS
containing 100 mM of NH4 Cl (Sigma-Aldrich, United States),
and washed three times with PBS containing 1.5% Bovine Serum
Albumin (PBS-BSA, Sigma-Aldrich, United States). Cells were
incubated for 1 h with anti-iNOS mouse monoclonal antibody
(sc-7271, Santa Cruz Biotechnology, United States) diluted 1:100
and anti-RH (SAG1) rabbit antibody diluted 1:2000 in PBSBSA, washed once in PBS and twice in PBS-BSA and incubated
with goat anti-mouse IgG monoclonal antibody conjugated to
Alexa Fluor 488 (Thermo Fisher Scientific, United States) diluted
1:200 and goat anti-rabbit IgG monoclonal antibody conjugated
to Alexa Fluor 594 (Thermo Fisher Scientific, United States)
diluted 1:2000 in PBS-BSA. Coverslips containing cells were
mounted with the Prolong Gold antifade reagent with DAPI
(Life Technologies, United States) and visualized with a Zeiss
Axioskop 2 MOT Plus epifluorescence microscope with a 63×
Plan Apochromat lens (numerical aperture of 1.40; Carl Zeiss,
Inc., Germany), equipped with an AxioCam MRm camera (Carl
Zeiss, Inc., Germany). Images were acquired using Axiovision
v4.6 (Carl Zeiss, Inc., Germany) and processed with Adobe
Photoshop 6.0 (Adobe Systems Inc., United States).

Macrophage Activation and Infection
The RAW 264.7 and J774-A1 cells were seeded at the density of
5 × 104 cells per well in 96-well plates, activated with 200 U/ml
of recombinant mouse IFN-γ (R&D Systems, United States) and
0.2 µg/ml of LPS from Escherichia coli 0111:B4 (Sigma-Aldrich,
United States) for 24 h prior of the T. gondii infection. After 24 h
of activation, cells were washed twice with sterile PBS, DMEM
supplemented with 3% FBS was added, cells were infected with
a 5 T. gondii per macrophage (5:1) ratio and incubated at 37◦ C
for 2 h. The T. gondii-macrophage ratio used was determined by
previous experiments examining NO production and number of
adhered macrophages after 24 h infection. After infection, cells
were washed twice in sterile PBS, and DMEM supplemented with
10% FBS with IFN-γ and LPS or these activators and L-arginine
(Sigma-Aldrich, United States) at different concentration, was
added. Supernatants were collected at 2, 4, 6, and 24 h after
infection for the nitrite assay.

Nitrite Oxide (NO) Production
The NO produced by macrophages was assayed by the
Griess reagent (Green et al., 1982). Briefly, 50 µl of cell
supernatant from each well were collected and distributed in
96-well plates and 50 µl of Griess reagent (1:1, 0.1% N(1-Naphthyl) ethylenediamine dihydrochloride (Sigma-Aldrich,
United States) in distilled water and 1% sulfanilamide (SigmaAldrich, United States) in 5% phosphoric acid (Sigma-Aldrich,
United States) were added. Plates were incubated at room
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Cell Analysis
To quantify the percentage of iNOS positive and iNOS
negative cells in infected or non-infected cells, RAW 264.7
and J774-A1 macrophages were seeded in black 96-well cellstar
microplates with clear bottom and condensation rings (BioTek,
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United States), activated and infected as described. Cells were
fixed with PBS containing 4% formaldehyde for 15 min, washed
three times with PBS and incubated for 15 min with FBS-NGS
containing 5 µg/ml of Wheat Germ Agglutinin conjugated to
Alexa Fluor 633 (Thermo Fisher Scientific, United States) for
total cell staining. Cells were washed twice in PBS and incubated
for 1 h with anti-iNOS mouse monoclonal antibody (Santa Cruz
Biotechnology, United States) diluted 1:100 in FBS-NGS and
anti-RH (SAG1) rabbit antibody diluted 1:10000 in 5% FBSNGS. Cells were washed twice with PBS and incubated with
goat anti-mouse IgG conjugated to Alexa Fluor 488 (Thermo
Fisher Scientific, United States) diluted 1:200 and goat antirabbit IgG conjugated to Alexa Fluor 594 (Thermo Fisher
Scientific, United States) diluted 1:2000 in FBS-NGS. Cell analysis
was performed with a Cytation 3 (BioTek, United States)
multimode plate imager equipped with Gen5 software and 20×
objective.

RESULTS
T. gondii Inhibits NO Production of
Activated Macrophages Independently of
Substrate Availability and Cell Type
To evaluate the ability of the parasite to inhibit NO production
in different macrophage cell lines, activated J774-A1 or RAW
264.7 cells were infected with T. gondii and nitrite production
was evaluated in culture supernatant at different time points.
Differences in the timing of inhibition of NO production were
observed between the two cell lines. In J774-A1 macrophages,
inhibition of NO production occurred by 2 h post-infection
(Figure 1A) and was sustained up to 24 h (Figure 1B).
In contrast, inhibition of NO production in RAW 264.7
macrophages occurred only after 6 h post-infection (Figure 1C)
and was sustained up to 24 h (Figure 1D).
During host cell invasion T. gondii secretes important
virulence factors including ROP16, which activates STAT 3 and
STAT 6 in macrophages resulting in upregulation of arginase 1
(ARG1) (Butcher et al., 2011). Induction of ARG1 competes with
iNOS for the substrate L-arginine (Butcher et al., 2011), hence this
may be a mechanism of avoiding NO production. To determine
if inhibition of NO production in activated macrophages was
caused by substrate depletion, we supplemented the culture
medium with increasing concentrations of L-arginine and
evaluated NO production after 24 h of infection. Treatment of
activated J774-A1 macrophages with increasing concentrations
of L-arginine did not enhance NO production in control or
infected cells, nor reverted the inhibition of NO production
phenotype caused by T. gondii infection (Figure 1E). In
contrast, incubation of activated RAW 264.7 macrophages
with increasing concentrations of L-arginine enhanced NO
production in control and infected cells, and yet it did not
reverse the inhibition of NO production in infected cells
(Figure 1F).

Western Blot and Densitometry Analysis
RAW 264.7 and J774-A1 macrophages were seeded at the density
of 2 × 106 cells per well in 6-well plate (TPP, Switzerland),
activated and infected as described. Cells were washed once in
sterile PBS and lysed with 50 µl of lysing buffer containing
50 mM of Tris–HCL (Sigma-Aldrich, United States), 150 mM
NaCl (Sigma-Aldrich, United States), 1% Triton X-100 (SigmaAldrich, United States) and protease inhibitor cocktail (SigmaAldrich, United States). Protein samples were frozen in liquid
nitrogen three times, centrifuged (Eppendorf, Germany) at
5,000 g, for 3 min and protein concentration was measured using
the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific,
United States). Samples were diluted 4:1 in 5× Laemmli
buffer containing 10 mM of dithiothreitol (Sigma-Aldrich,
United States), boiled for 5 min, resolved in 8% polyacrylamide
gels (Bio-Rad Laboratories, Inc., United States) by SDS–PAGE,
and transferred to nitrocellulose membranes Amersham Protran
0.45 NC (GE Healthcare Life Sciences, United States) for 1 h.
Membranes were blocked overnight at 4◦ C with 5% fat-free
milk in PBS 0.1% Tween 20 (Sigma-Aldrich, United States),
probed for 1 h with anti-iNOS mouse monoclonal antibody
(Santa Cruz Biotechnology, United States) dilute 1:1000 and
rabbit anti-β-actin (Cell Signaling Technology, United States)
diluted 1:1000 in 5% fat-free milk in PBS 0.1% Tween 20.
Membranes were washed with PBS 0.1% Tween 20 and labeled
for 1 h with IR dye-conjugated secondary antibodies (LI-COR
Biosciences, United States) against mouse and rabbit dilute
1:15000 and visualized on a LiCor Odyssey Imaging System (LICOR Biosciences, United States). Western blots were quantified
using the software ImageJ and intensity values were normalized
to β-actin at each time interval.

iNOS Expression in Infected
Macrophages Is Dependent on Cell Line
Type
To examine whether the inhibition of NO production in activated
J774-A1 macrophage was caused by protein degradation, iNOS
expression was evaluated by different methods. iNOS showed
variable levels of expression in activated non-infected J774-A1
macrophages based on IFA staining (Figure 2A). Following
infection with T. gondii there were more iNOS negative
cells at 24 h post-infection (Figure 2A). This finding was
confirmed by analyzing the proportion of activated cells that
were positive for iNOS in non-infected cells (Control) and
T. gondii challenged cells (Non-infected or Infected) as depicted
in Figure 2B. Although there was a tendency to decrease the
number of iNOS positive cells in infected macrophages at 2 h,
this effect was significant at 24 h post-infection (Figure 2B).
Western blot (Figure 2C and Supplementary Figure 1) and
densitometry analysis (Figure 2D) also confirmed inhibition of
iNOS expression in cells infected for 24 h. However, reduction

Statistical Analysis
Statistical analyses were conducted with Prism 7 (GraphPad
Software Inc., United States), and differences in the means were
assessed by one-way or two-way ANOVA with Tukey’s multiple
comparison post-test, or unpaired Student’s t-test. P ≤ 0.05 was
the cutoff considered minimum for significance.
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FIGURE 1 | Nitric oxide (NO) production (nitrite in µM) in activated J774-A1 and RAW 264.7 cells macrophages after T. gondii infection. (A) NO production of
non-infected (Control) or T. gondii (RH) infected J774-A1cells at 6 h and (B) 24 h post-infection. Mean ± SEM (n = 3 experiments, each with 12 replicates). (C) NO
production of non-infected (Control) or T. gondii (RH) infected RAW 264.7 cells at 6 h and (D) 24 h post-infection. Mean ± SEM (n = 3 experiments, each with 12
replicates). ns (not significant), ∗ P ≤ 0.05, ∗∗ P ≤ 0.01, ∗∗∗ P ≤ 0.001, two-way ANOVA with Tukey post-test. (E) NO production of non-infected (Control) or T. gondii
(RH) infected J774-A1 (F) or RAW 264.7 cells for 24 h with normal medium or supplemented with different levels of L-arginine. Mean ± SEM (n = 3 experiments,
each with 6 replicates). ∗ P ≤ 0.05 and ∗∗ P ≤ 0.01, ∗∗ P ≤ 0.01, ∗∗∗ P ≤ 0.001, ∗∗∗∗ P ≤ 0.0001 one-way ANOVA with Tukey post-test, # P ≤ 0.05 comparing the
“Control” or “Infected” bar with the respective “Normal medium” bar.
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FIGURE 2 | Immunofluorescence detection of iNOS in activated J774-A1 macrophages infected with T. gondii. (A) Detection of iNOS (green) in non-infected
(Control) and in T. gondii (red) infected cells (DAPI - blue) at 2, 6, and 24 h post-infection. Scale bar = 10 µm. (B) Analysis of the proportion of iNOS positive or
negative macrophages in non-infected (Control) and T. gondii infected cells at 2 and 24 h post-infection. Mean ± SEM (n = 4 experiments, each with 8 replicates).
(C) Western blot detection of iNOS expression in non-infected (Control) and T. gondii infected (Infected) cells. β-actin was used as loading control. (D) Densitometry
of western blots normalized to β-actin at 2 h post-infection. Mean ± SD (n = 3 experiments, each with 1 replicate). ∗ P ≤ 0.05, two-way ANOVA with Tukey post-test,
n.s (not significant).

in iNOS expression was not observed at earlier time points after
infection (Figure 2D).
We also analyzed iNOS expression after T. gondii infection
of RAW 264.7 macrophages using similar IFA and Western

Frontiers in Microbiology | www.frontiersin.org

blot analyses. The signal intensity of iNOS expression in
RAW 264.7 cells was much higher, with all uninfected cells
being uniformly positive (Figure 3A and Supplementary
Figure 2). No difference in iNOS expression by IFA was
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FIGURE 3 | Immunofluorescence detection of iNOS in activated RAW 264.7 macrophages infected with T. gondii. (A) Detection of iNOS (green) in non-infected
(Control) and in T. gondii (red) infected cells (DAPI - blue) at 2, 6, and 24 h post-infection. Scale bar - 10 µm. (B) Analysis of the proportion of iNOS positive or
negative macrophages in non-infected (Control) and T. gondii infected cells at 2 and 24 h post-infection. Mean ± SEM (n = 4 experiments, each with 8 replicates).
(C) Western blot detection of iNOS expression in non-infected (Control) and T. gondii - infected (Infected) cells at different time intervals post-infection. β-actin was
used as loading control. (D) Densitometry of western bolts normalized to β-actin at 2 h post-infection. Mean ± SD (n = 3 experiments, each with 1 replicate), n.s (not
significant).

observed between non-infected and infected RAW 264.7
macrophages at 24 h post-infection (Figure 3A). This finding
was confirmed by analyzing the proportion of cells that
were positive for iNOS. In non-infected and T. gondii

Frontiers in Microbiology | www.frontiersin.org

challenged RAW 264.7 macrophage populations, most of the cells
remained iNOS positive up to 24 h post-infection (Figure 3B).
Similarly, no difference in iNOS expression between control
and infected cells was observed by Western blot (Figure 3C)
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FIGURE 4 | Analysis of ROP and ASP5, MYR1, and IST deletion mutants on the ability of T. gondii to inhibit NO production (nitrite in µM) of activated macrophages.
(A) NO production of non-infected (Control) or activated J774-A1 cells infected with parental (RH1ku80 strain) or various ROP deletion strains of T. gondii at 24 h
post-infection. Mean ± SEM (n = 3 experiments, each with 12 replicates). ∗∗∗∗ P ≤ 0.0001, one-way ANOVA with Tukey post-test. (B) NO production of non-infected
(Control) or activated J774-A1 cells infected with parental (RH1ku80 strain) or 1asp5, 1myr1, or 1ist mutant strains of T. gondii at 24 h post-infection.
Mean ± SEM (n = 3 experiments, each with 12 replicates). ∗∗∗∗ P ≤ 0.0001, one-way ANOVA with Tukey post-test. (C) NO production of non-infected (Control) or
activated RAW 264.7 cells infected with parental (RH1ku80 strain) or various ROP deletion strains of T. gondii at 24 h post-infection. Mean ± SEM (n = 3
experiments, each with 12 replicates). ∗ P ≤ 0.05, ∗∗ P ≤ 0.01, ∗∗∗ P ≤ 0.001, ∗∗∗∗ P ≤ 0.0001, one-way ANOVA with Tukey post-test. (D) NO production of
non-infected (Control) or activated RAW 264.7 cells infected with parental (RH1ku80 strain) or 1asp5, 1myr1, and 1ist mutant strains of T. gondii at 24 h
post-infection. Mean ± SEM (n = 3 experiments, each with 12 replicates). ∗ P ≤ 0.05, ∗∗ P ≤ 0.01, one-way ANOVA with Tukey post-test.

and densitometry analysis (Figure 3D) at different time points
post-infection.

the parent RH line to a series of ROP deletion mutants
(Figures 4A,C). We also examined the ability of a 1rop16
mutant to alter this phenotype, since this kinase has previously
been shown to activate STAT3/STAT6 and hence activate ARG1
(Butcher et al., 2011). The rop16 mutant showed a similar
capacity to block NO production in activated J774-A1 and
RAW 264.7 cells (Figures 4A,C). The various knockout parasites
presented no deficiency in entry in activated J774-A1 or RAW
264.7 macrophages (Supplementary Figure 3).
We also tested T. gondii mutants in the modulator IST that
inhibits STAT1 transcription (Hakimi et al., 2017). These mutants
had no effect on the NO inhibition phenotype (Figures 4B,D).
Recently, the major role of the Golgi-associated protein, ASP5,
and the parasitophorous vacuole (PV) associated protein, MYR1,
in the cleavage and export of some dense granule effector
proteins across the vacuole membrane into the host cell has been
demonstrated (Curt-Varesano et al., 2016; Franco et al., 2016).

Evaluation of T. gondii Virulence Factors
Do Not Influence Inhibition of NO
Production
A number of previous virulence factors have been identified
in T. gondii including a complex of ROP kinases consisting of
ROP5, ROP17, and ROP18 that participates in defense of the
parasitophorous vacuole by thwarting IRGs (Hunter and Sibley,
2012). To determine whether the inhibition of NO production
in infected activated J774-A1 and RAW 264.7 macrophages was
dependent on the ROP kinases, we examined the inhibition
of NO production in activated macrophages infected with a
series of mutants. Inhibition of NO production was similar in
both macrophage cell lines at 24 h infection when comparing
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the RAW 264.7 line from a tumor induced by Abelson murine
leukemia virus (Ralph and Nakoinz, 1977) both in BALB/c mice.
Furthermore, exposure of both cell lines to Streptococcus iniae
induces a higher respiratory burst response in RAW 264.7 than
in J774-A1 macrophage (El Aamri et al., 2015). Moreover, RAW
264.7 produces 30-fold higher TNF-α mRNA than J774-A1 after
LPS stimulation (Heming et al., 2001). These differences help to
explain the higher expression of iNOS in RAW 264.7 compared
to J774-A1 macrophages. In addition, a gene expression profile
study (Lindmark et al., 2004) shows that J774-A1 is closer
to peritoneal mice macrophages than RAW 264.7, despite the
fact that both cell lines were derived from transformed cells
obtained from ascites (Ralph and Nakoinz, 1977). Our findings
reveal that T. gondii infection can down-regulate NO production
in these different macrophage cell lines, albeit by different
mechanisms.
During host cell infection, T. gondii secrets the content of
rhoptries and dense granules ensuring the establishment of
infection and hijacking host cell-autonomous immunity (Sibley,
2011). ROP and GRA proteins form complexes that protect
T. gondii PV by avoiding recruitment of IRGs (Hunter and
Sibley, 2012). GRA proteins are also exported across the PV
altering important host functions (Hakimi et al., 2017). TgIST
is a GRA effector that represses STAT1 transcription blocking
gene expression induced by IFN-γ (Gay et al., 2016; Olias
et al., 2016). In addition, the export and traffic of GRAs
across the PV and into the host cell are dependent of ASP5
(Coffey et al., 2015; Curt-Varesano et al., 2016) and MYR1
(Franco et al., 2016). However, these virulence factors have not
previously been evaluated for their ability to modulate other
important host microbicidal systems such as NO production.
Thus, knockout parasites were used to investigate whether
some rhoptry proteins (ROP5, ROP16, ROP17, ROP18). The
parasite ROP16 kinase has been implicated in modulating NO
production in microglial cells and astrocytes (Butcher et al.,
2011). However, the knockout in ROP16 did not affect the
down modulation of NO production in either of the macrophage
cells lines studied here. Additionally, the ROP5-ROP17-ROP18
complex, which has been implicated in blocking IRG-mediated
clearance, did not affect the down modulation of NO production
in T. gondii – infected cells. We also explored the roles of the
GRA TgIST, or components of the PV membrane translocation
system (ASP5, MYR1) for involvement in NO production
control in infected macrophages. These GRA knockout parasites
were able to inhibit NO production similar to the parental
strain in J774-A1 and RAW 264.7 macrophages. These results
indicate that the parasite effector that down modulates NO
production is independent of TgIST, including other modulators
that depend on the trafficking pathway based on ASP5 and
MYR1.
Overall, our findings reveal that the strategy adopted by
T. gondii to inhibit NO production in activated macrophages is
independent of previously characterized virulence factors, such
as the ROP5-ROP17-ROP18 complex, ROP16, GRA effectors,
and the ASP5 and MYR1 export pathway. Thus, a possibly new
parasite effector is involved in NO production inhibition in
these cells. The mechanism causing NO production inhibition

Therefore we examined the ability of mutants in these effectors
to block the production of NO in activated macrophages.
After infection, all knockout parasites were able to inhibit NO
production of activated J774-A1 (Figure 4B) and RAW 264.7
macrophages (Figure 4D) similar to the parental parasite. The
various knockout parasites presented no deficiency in entry in
activated J774-A1 or RAW 264.7 macrophages (Supplementary
Figure 3).

DISCUSSION
Toxoplasma gondii has many evasion mechanisms including
the capacity to inhibit NO production of infected activated
macrophages (Dobbin et al., 2002; Seabra et al., 2002, 2004;
Luder et al., 2003; Padrao Jda et al., 2014). NO production
inhibition, iNOS expression and the role of some T. gondii
effectors were studied in parallel using two macrophage cell
lines. Infection of both cell lines caused inhibition of NO
production. However, only in J774-A1 macrophages was NO
inhibition detected at early stages of infection (i.e., 2 h postinfection), while inhibition was seen starting at 6 h postinfection in both lines. Addition of extra L-arginine substrate
to both macrophage lines did not change NO production
inhibition, indicating that this result is not due to substrate
limitation. Interestingly, reduction of iNOS expression after
infection was only detected in J774-A1 cells, with RAW 264.7
presenting the same levels as non-infected cells. Finally, knockout
parasites in known effectors were able to inhibit NO production
similar to the parental strain. Our findings suggest that the
inhibition of NO production of activated macrophages infected
by T. gondii is a general phenomenon, but iNOS suppression
varies depending on the macrophage cell line. In addition, it is
likely that a novel parasite effector is responsible for this evasion
mechanism.
Toxoplasma gondii infection causes ARG1 expression that
competes with iNOS for L-arginine (El Kasmi et al., 2008; Butcher
et al., 2011). However, extra L-arginine did not reverse NO
production inhibition in either infected cell lines, indicating that
the reduction in NO production is not due to substrate limitation.
Following addition of L-arginine, J774-A1 produced the same
amount of NO while RAW 264.7 macrophages responded to
this addition by producing more NO. This finding is consistent
with the differences in iNOS expression, and provides a further
distinction in phenotypes between these two lines (Heming et al.,
2001; Lindmark et al., 2004; El Aamri et al., 2015).
Previous report showed that NO production inhibition of
T. gondii infected activated mice peritoneal macrophages was
related to iNOS degradation (Seabra et al., 2002, 2004), which
involves the proteasome in J774-A1 macrophages (Padrao Jda
et al., 2014). Down modulation of iNOS expression was verified
in infected J774-A1 but this was not observed in RAW 264.7
macrophages. These results suggest that the strategy adopted
by T. gondii to inhibit NO production may be specific to
the host cell, due to the intrinsic characteristics and origin
of each macrophage cell line. The J774-A1 line was originally
established from reticulum cell sarcoma (Hirst et al., 1971) while
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of macrophages infected by T. gondii varies depending on the
host cell background: it involves reduction of iNOS expression
in J774-A1 and iNOS impairment in RAW 264.7. This may be
relevant to in vivo infections where T. gondii infects and needs to
cope with distinct macrophage populations.
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